דקסמתזון קרן פארמה - Dexamethasone kern pharma
×××ר××
×צפ××× ×××××¢ ××ר×× ×ר×פ××× ×ש ××××× ×¡ ××ש××× ×. ×× ××× × ×¨×©×× ××× ×¡ ××רש×× ×ר×פ××× ××× ×©× ×קצ××¢×ת רפ×××××.
× ×ª×× × ×ª×¨×פ×
×××¨×©× 
| ×§×××¦× ×¤×¨××§×××××ת (ATC4) | H02AB Glucocorticoids | |||||
|---|---|---|---|---|---|---|
| ×ר××× ×¤×¢×× (ATC5) | Â
| |||||
| צ×רת ××ª× | ת××-שר×ר×, ת××-×ר××× - I.V; I.M | |||||
| צ×רת ××× ×× | ת×××¡× ×××רק×, SOLUTION FOR INJECTION ××× ×עת ××× ×× ×תר ×× ×רע×× ×ש ××××× ×ת ×תר××¤× ××ת×× ×××× ×× ××××××¥ ××¤× ×©××פ××¢ ××¢××× ×צר×× | |||||
| ×ת×××× | Dexamethasone Kern Pharma is indicated in the treatment of:⢠Endocrine diseases such as nonsuppurative thyroiditis, hypercalcaemia associated with cancer and congenital adrenal hyperplasia.⢠Allergy: Severe or disabling allergic conditions resistant to conventional treatments, as in: bronchial asthma, contact or atopical dermatitis, seasonal or perennial allergic rhinitis, hypersensitivity reactions to drugs.⢠Ophtalmic: Serious inflammatory and allergic processes, acute and chronic, affecting the eyes, such as: iritis and iridocyclitis, chorioretinitis, choroiditis and diffuse posterior uveitis, optical neuritis, allergic conjunctivitis, allergic marginal corneal ulcers.⢠Inflammatory Bowel dis.: Systemic treatment in exacerbations of ulcerative colitis and regional enteritis.⢠Dermatological diseases (pemphigus, Stevens Johnson syndrome, exfoliative dermatitis, severe psoriasis and mycosis fungoides) ⢠Respiratory diseases (symptomatic sarcoidosis, berylliosis, Loeffler's syndrome)⢠Haematological: acquired )autoimmune( haemolytic anaemia, idiopathic thrombocytopenic purpura in adult, pure red cell aplasia⢠Nephrotic syndrome of the idioplathic type or that due to lupus erythematosus⢠Cerebral edema caused by brain tumor, neurosurgery, brain abscess, bacterial meningitis⢠Collagen diseases: Active rheumatoid arthritis with severe progressive course, fast destructive remitting forms and / or extra-articular manifestations, Juvenile idiopathic arthritis with severe systemic-onset form (Still's disease) or locally with no control, rheumatic fever with carditis, dermatomyositis, polymyositis, SLE, temporal arteritis.⢠Infectious Diseases: Bacterial meningitis â adjunct to antibiotics in suspected Pneumococcal meningitis and TB meningitis. Severe infectious diseases with toxic states (eg tuberculosis, typhoid, brucellosis;. Only with simultaneous anti-infective therapy)⢠Fetal lung maturation⢠Chemotherapy â associated nausea and vomiting⢠Multiple Myeloma â part of chemotherapy protocols (eg VAD)⢠Prevention and treatment of acute mountain sickness/HACE
| |||||
× ×ª×× × ×¡× [ ×צ×× ]
| ||||||
| ×¢××× ×ר××¤× ××××ר×ת ××¢××× |
  | |||||
| ×¢××× ×צר×× |  |
|---|
| ער××× ×××××§×רפ××× | ער××× ×§×©×ר×× ×××××§×רפ××× |
|---|---|
| ×קס×ת××× ×§×¨× ×¤×ר×× ××××ר ××©×¨× ××ר×××ת |
| ××פ×ש ×××ר×× | ×××ר×× ×-PubMed |
|---|---|
| ××××¢ ×רשת | RxList WebMD Drugs.com |
| ×©× ××¦×¨× | KERN PHARMA S.L, SPAIN |
| ×©× ××¢× ×ר×ש×× | MBI PHARMA LTD., ISRAEL |
| ר×ש××× | ת×ר×× ××ש×: 02/2014. ר×ש××× ×ת×ר××: 02/2016 |
| ת×ר×× ×¢×××× ××ר×× | 14/05/19 |